Health ❯Healthcare

Vaccines

Vaccines Vaccination Public Health Health Policy Vaccines Pharmaceuticals Corporate Finance Immunology Political Parties Senate

HHS Implements Controversial Vaccine Trial Mandate Under RFK Jr.

New policy requiring placebo-controlled trials for all vaccines raises ethical concerns and warns of delays for flu shots and COVID-19 boosters.

Shingles Vaccine Found to Reduce Cardiovascular Risks by Up to 26%

HHS and NIH Launch $500 Million Universal Vaccine Initiative Using Whole-Virus Approach

FDA Demands New Trials for Novavax COVID Vaccine, Raising Concerns Over Fall Booster Rollouts

Merck Lowers 2025 Profit Forecast as Tariffs and Licensing Costs Weigh

Federal Vaccine Panel Expands RSV, Meningitis, and Chikungunya Recommendations

John Rich's Advice to Trump Shaped Vaccine Messaging Strategy

Shingles Vaccine Linked to 20% Reduction in Dementia Risk, Study Finds

NICE Approves Brentuximab Vedotin for Advanced Hodgkin Lymphoma on NHS

Linda McMahon Addresses Potential Shift in Vaccine Policy Oversight and RFK Jr.'s Role

NIH Directs Scientists to Remove mRNA Vaccine References, Raising Fears of Research Cuts

Vaxart's Oral Norovirus Vaccine Shows Promise in Early Trials for Elderly Adults

FDA and CDC Vaccine Meetings Canceled, Raising Concerns Over Flu Shot Supply and Transparency

Novavax Reports Narrower Q4 Loss and Strategic Shift Away from COVID-19 Vaccine Commercialization

Moderna Reports Larger-Than-Expected Q4 Loss as COVID Vaccine Sales Plummet

Sen. Susan Collins Backs RFK Jr. for Health Secretary Amid Widespread Criticism

RFK Jr.'s HHS Nomination Advances to Senate Floor Following Divisive Committee Vote

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

RFK Jr.'s Nomination for HHS Secretary Faces Senate Finance Committee Vote

RFK Jr.'s HHS Nomination Faces Bipartisan Scrutiny Over Vaccine Stance and Financial Ties